Zobrazeno 1 - 10
of 476
pro vyhledávání: '"Ashesh B, Jani"'
Autor:
Nikhil T. Sebastian, Subir Goyal, Yuan Liu, Vishal Dhere, Ashesh B. Jani, Bruce Hershatter, Pretesh R. Patel, Jay W. Shelton, Sheela Hanasoge, Karen D. Godette, Sagar A. Patel
Publikováno v:
Journal of Contemporary Brachytherapy, Vol 16, Iss 4, Pp 268-272 (2024)
Externí odkaz:
https://doaj.org/article/406150dafd314b69b925aefcd73e21f9
Autor:
Benjamin H. Lowentritt, MD, Ashesh B. Jani, MD, Brian T. Helfand, MD, Edward M. Uchio, MD, Michael A. Morris, MD, Jeff M. Michalski, MD, Albert Chau, MSc, Phillip Davis, MD, Brian F. Chapin, MD, David M. Schuster, MD
Publikováno v:
Advances in Radiation Oncology, Vol 9, Iss 8, Pp 101532- (2024)
Purpose: 18F-Flotufolastat (18F-rhPSMA-7.3) is a newly approved prostate-specific membrane antigen targeting radiopharmaceutical for diagnostic imaging of prostate cancer (PCa). SPOTLIGHT (National Clinical Trials 04186845) evaluated 18F-flotufolasta
Externí odkaz:
https://doaj.org/article/0a78797c6fb84535b5a1b6769c51c1c9
Autor:
Tonghe Wang, Yang Lei, Eduard Schreibmann, Justin Roper, Tian Liu, David M. Schuster, Ashesh B. Jani, Xiaofeng Yang
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Background and purposeA novel radiotracer, 18F-fluciclovine (anti-3-18F-FACBC), has been demonstrated to be associated with significantly improved survival when it is used in PET/CT imaging to guide postprostatectomy salvage radiotherapy for prostate
Externí odkaz:
https://doaj.org/article/70580af08bc3407f8cc5399fe4143f63
Autor:
Benjamin W. Fischer-Valuck, Brian C. Baumann, Simon A. Brown, Christopher P. Filson, Aaron Weiss, Ryan Mueller, Yuan Liu, Randall J. Brenneman, Martin Sanda, Jeff M. Michalski, Hiram A. Gay, Yuan James Rao, John G. Pattaras, Ashesh B. Jani, Bruce Hershatter, Sagar A. Patel
Publikováno v:
European Urology Open Science, Vol 37, Iss , Pp 80-89 (2022)
Background: Elderly patients diagnosed with high-risk prostate cancer (PCa) present a therapeutic dilemma of balancing treatment of a potentially lethal malignancy with overtreatment of a cancer that may not threaten life expectancy. Objective: To in
Externí odkaz:
https://doaj.org/article/bed16021cbda402da7800649e253f019
Autor:
Jacqueline T. Brown, Vikram M. Narayan, Shreyas S. Joshi, Lara Harik, Ashesh B. Jani, Mehmet Asim Bilen
Publikováno v:
Cancer Treatment and Research Communications, Vol 34, Iss , Pp 100663- (2023)
Urothelial carcinoma accounts for approximately 90% of all bladder cancer diagnoses. Localized, muscle-invasive disease is often managed with a multidisciplinary approach including either neoadjuvant chemotherapy (NAC) followed by radical cystectomy
Externí odkaz:
https://doaj.org/article/2d15cfb2dd024c29b7b884d6ad9c8807
Autor:
Robert H. Press, MD, Joseph W. Shelton, MD, Chao Zhang, PhD, Quang Dang, CMD, Sibo Tian, MD, Timothy Shu, MPH, Crystal S. Seldon, MD, Shaakir Hasan, DO, Ashesh B. Jani, MD, FASTRO, Jun Zhou, PhD, Mark W. McDonald, MD
Publikováno v:
International Journal of Particle Therapy, Vol 8, Iss 3, Pp 1-10 (2021)
Purpose: For patients with high-risk bladder cancer (pT3+ or N+), local regional failure remains a challenge after chemotherapy and cystectomy. An ongoing prospective phase 2 trial (NCT01954173) is examining the role of postoperative photon radiation
Externí odkaz:
https://doaj.org/article/0d4e73d0e27d4a29a1774b6d338d4ed1
Autor:
James R. Janopaul-Naylor, MD, Tian Liu, PhD, Boran Zhou, PhD, Xiaofeng Yang, PhD, Neal S. McCall, MD, Pretesh R. Patel, MD, Akanksha Mehta, MD, MS, Sherif G. Nour, MD, Ashesh B. Jani, MD, MSEE
Publikováno v:
Advances in Radiation Oncology, Vol 7, Iss 5, Pp 100946- (2022)
Externí odkaz:
https://doaj.org/article/7e9cca48a6a7415f88657eab4b872acf
Autor:
James Robert Janopaul-Naylor, Jim Zhong, Yuan Liu, Chao Zhang, Adeboye O. Osunkoya, Shreyas Subhash Joshi, Mehmet Asim Bilen, Bradley Carthon, Omer Kucuk, Lindsey Marie Hartsell, Joseph Shelton, Ashesh B. Jani
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 26, Iss , Pp 30-34 (2021)
Purpose: For muscle-invasive bladder cancer, bladder preserving chemoradiotherapy (BPCRT) has shown to be a viable alternative for patients with urothelial carcinoma (UCa). Traditionally bladder cancer with variant histology UCa or other tumors types
Externí odkaz:
https://doaj.org/article/1e85af579fb94ecd921ae759aa66683e
Autor:
Sagar A. Patel, Jeffrey M. Switchenko, Ben Fischer-Valuck, Chao Zhang, Brent S. Rose, Ronald C. Chen, Ashesh B. Jani, Trevor J. Royce
Publikováno v:
Radiation Oncology, Vol 15, Iss 1, Pp 1-7 (2020)
Abstract Background Ultrahypofractionation using stereotactic body radiotherapy (SBRT) is an increasingly utilized technique for men with prostate cancer (PC). The comparative efficacy of SBRT plus androgen deprivation therapy (ADT) compared to fract
Externí odkaz:
https://doaj.org/article/23b99fde720845aca8d0730f3178701a
Autor:
Neal S. McCall, MD, Yuan Liu, PhD, Sagar A. Patel, MD, Bruce Hershatter, MD, Drew Moghanaki, MD, Karen D. Godette, MD, Sheela Hanasoge, MD, PhD, Pretesh Patel, MD, Benjamin W. Fischer-Valuck, MD, Joseph W. Shelton, MD, Ashesh B. Jani, MD
Publikováno v:
Advances in Radiation Oncology, Vol 6, Iss 6, Pp 100803- (2021)
Purpose: Treatment with long-term androgen deprivation therapy (ADT) and radiation therapy (RT) is the nonsurgical standard-of-care for patients with high- or very high-risk prostate cancer (HR-PC), but the optimal timing between ADT and RT initiatio
Externí odkaz:
https://doaj.org/article/510c544551994ec9be4490c754652515